Laser Therapy for Treatment of Urogenital Symptoms in Women

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 8, 2018

Primary Completion Date

December 15, 2022

Study Completion Date

June 10, 2025

Conditions
Genitourinary System; Disorder, FemaleBurning VaginaDyspareuniaIrritation; VaginaMenopause Related ConditionsUrinary IncontinenceUrinary Bladder, OveractiveUrinary Tract InfectionsStress Urinary Incontinence
Interventions
DEVICE

fCO2 Laser Therapy Group

Women enrolled in the study will receive three treatments with the fractional carbon dioxide (fCO2) laser. The interval between treatments is approximately six weeks. Intra-vaginal laser treatments will be delivered at 8 points at each level of the vaginal wall.

Trial Locations (1)

48073

Beaumont Hospital, Royal Oak

All Listed Sponsors
lead

William Beaumont Hospitals

OTHER

NCT03681678 - Laser Therapy for Treatment of Urogenital Symptoms in Women | Biotech Hunter | Biotech Hunter